Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BDX | Common Stock | Options Exercise | $1.34M | +14.3K | +241.67% | $93.49 | 20.3K | Aug 9, 2022 | Direct | |
transaction | BDX | Common Stock | Disposed to Issuer | -$1.34M | -5.14K | -25.38% | $260.44 | 15.1K | Aug 9, 2022 | Direct | |
transaction | BDX | Common Stock | Sale | -$2.39M | -9.19K | -60.78% | $260.44 | 5.93K | Aug 9, 2022 | Direct | F1, F2 |
transaction | BDX | Common Stock | Options Exercise | $1.35M | +12.5K | +210.68% | $108.25 | 18.4K | Aug 9, 2022 | Direct | |
transaction | BDX | Common Stock | Disposed to Issuer | -$1.35M | -5.19K | -28.2% | $260.44 | 13.2K | Aug 9, 2022 | Direct | |
transaction | BDX | Common Stock | Sale | -$1.9M | -7.3K | -55.17% | $260.44 | 5.93K | Aug 8, 2022 | Direct | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BDX | Stock Appreciation Rights | Options Exercise | $0 | +14.3K | $0.00* | 0 | Aug 9, 2022 | Common Stock | 14.3K | $93.49 | Direct | F3, F4 | |
transaction | BDX | Stock Appreciation Rights | Options Exercise | $0 | +12.5K | $0.00* | 0 | Aug 9, 2022 | Common Stock | 12.5K | $108.25 | Direct | F3, F4 |
Id | Content |
---|---|
F1 | The reported sale price reflects the weighted average sale price for multiple transactions. The actual prices for the transactions ranged from $260.00 through $261.71. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request. This transaction was made pursuant to a 10b5-1 plan entered into on May 11, 2022. |
F2 | Direct holdings reflect adjustments made in connection with the spin-off of Embecta Corp. to the number of shares underlying previously reported and unvested time-vested restricted stock units held by the reporting person. |
F3 | Award terms reflect adjustments made in connection with the spin-off of Embecta Corp. |
F4 | The stock appreciation rights vest in four annual installments beginning one year from grant. |